Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Liabilities and Shareholders Equity: 2020-2024

Historic Liabilities and Shareholders Equity for Agilon Health (AGL) over the last 5 years, with FY2024 value amounting to $1.7 billion.

  • Agilon Health's Liabilities and Shareholders Equity fell 2367.62% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 billion, marking a year-over-year decrease of 1607.39%. This contributed to the annual value of $1.7 billion for FY2024, which is 39.54% down from last year.
  • As of FY2024, Agilon Health's Liabilities and Shareholders Equity stood at $1.7 billion, which was down 39.54% from $1.7 billion recorded in FY2023.
  • In the past 5 years, Agilon Health's Liabilities and Shareholders Equity ranged from a high of $1.7 billion in FY2023 and a low of $446.4 million during FY2020
  • Its 5-year average for Liabilities and Shareholders Equity is $1.4 billion, with a median of $1.7 billion in 2022.
  • In the last 5 years, Agilon Health's Liabilities and Shareholders Equity soared by 25537.42% in 2021 and then plummeted by 39.54% in 2024.
  • Over the past 5 years, Agilon Health's Liabilities and Shareholders Equity (Annual) stood at $446.4 million in 2020, then soared by 255.37% to $1.6 billion in 2021, then grew by 7.01% to $1.7 billion in 2022, then grew by 2.56% to $1.7 billion in 2023, then dropped by 0.4% to $1.7 billion in 2024.
  • Its Liabilities and Shareholders Equity was $1.7 billion in FY2024, compared to $1.7 billion in FY2023 and $1.7 billion in FY2022.